Intelligent Investor

Admedus Ltd (ASX: AHZ) - Announcements

- Current share price for AHZ : $7.200

ASX company news and announcements for Admedus Ltd (AHZ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Admedus Ltd (AHZ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Admedus Ltd (AHZ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Admedus Ltd (AHZ)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- CardioCel 3D and VascuCel European regulatory approval 11 Mar 2019 8:25AM $0.035 $7.200 $7.640 risen by 20,471.43%
- Appendix 3B 5 Mar 2019 9:44AM $0.033 $7.200 $7.640 risen by 21,718.18%
- Preliminary Final Report for period to 31 December 2018 1 Mar 2019 8:17AM $0.033 $7.200 $7.640 risen by 21,718.18%
- Appendix 4E and Preliminary Final Report 1 Mar 2019 8:16AM $0.033 $7.200 $7.640 risen by 21,718.18%
- Response to ASX Appendix 4C Query 20 Feb 2019 10:12AM $0.039 $7.200 $7.640 risen by 18,361.54%
- Promising Interim Results from TAVR Animal Study 19 Feb 2019 8:21AM $0.034 $7.200 $7.640 risen by 21,076.47%
- Change of Registered Address 30 Jan 2019 10:15AM $0.043 $7.200 $7.640 risen by 16,644.19%
- Change in substantial holding 21 Jan 2019 5:32PM $0.048 $7.200 $7.640 risen by 14,900%
- Becoming a substantial holder 21 Jan 2019 10:21AM $0.051 $7.200 $7.640 risen by 14,017.65%
- Appendix 4C - quarterly 21 Jan 2019 10:06AM $0.052 $7.200 $7.640 risen by 13,746.15%
- Change of Director's Interest Notice 21 Dec 2018 5:31PM $0.053 $7.200 $7.640 risen by 13,484.91%
- Initial Director's Interest Notice 19 Dec 2018 8:52AM $0.061 $7.200 $7.640 risen by 11,703.28%
- Initial Director's Interest Notice 19 Dec 2018 8:50AM $0.061 $7.200 $7.640 risen by 11,703.28%
- Appendix 3B 18 Dec 2018 12:49PM $0.061 $7.200 $7.640 risen by 11,703.28%
- NOTICE OF DELAY OF ALLOTMENT IN SHARES 17 Dec 2018 10:54AM $0.063 $7.200 $7.640 risen by 11,328.57%
- Entitlement Offer Shortfall Notice 14 Dec 2018 3:24PM $0.060 $7.200 $7.640 risen by 11,900%
- Director Appointments 12 Dec 2018 10:00AM $0.070 $7.200 $7.640 risen by 10,185.71%
- Despatch of rights issue offer documents 4 Dec 2018 10:48AM $0.054 $7.200 $7.640 risen by 13,233.33%
- Despatch of letters to eligible and ineligible shareholders 4 Dec 2018 10:46AM $0.054 $7.200 $7.640 risen by 13,233.33%
- Chief Medical Officer Appointment 4 Dec 2018 8:37AM $0.052 $7.200 $7.640 risen by 13,746.15%
- Reinstatement to Official Quotation 28 Nov 2018 10:21AM $0.135 $7.200 $7.640 risen by 5,233.33%
- Appendix 3B 28 Nov 2018 10:21AM $0.135 $7.200 $7.640 risen by 5,233.33%
- Admedus Prospectus - rights issue 28 Nov 2018 10:21AM $0.135 $7.200 $7.640 risen by 5,233.33%
- Admedus launches rights issue 28 Nov 2018 10:21AM $0.135 $7.200 $7.640 risen by 5,233.33%
- Interim CFO Appointment 26 Nov 2018 9:48AM $0.135 $7.200 $7.640 risen by 5,233.33%

76 - 100 of 444 results

Page 4 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.